Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma

JAMA Ophthalmol. 2015 Aug;133(8):965-7. doi: 10.1001/jamaophthalmol.2015.1128.

Authors

Dimosthenis Mantopoulos¹, Kari L Kendra², Alan D Letson¹, Colleen M Cebulla¹

Affiliations

¹ Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University, Wexner Medical Center, Columbus.
² Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Wexner Medical Center, Columbus.

No abstract available

Publication types

Case Reports
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antibodies, Monoclonal / adverse effects*
Choroid Diseases / chemically induced*
Choroid Diseases / diagnosis
Female
Fluorescein Angiography
Humans
Ipilimumab
Magnetic Resonance Imaging
Melanoma / drug therapy*
Multimodal Imaging
Retinal Detachment / chemically induced*
Retinal Detachment / diagnosis
Skin Neoplasms / drug therapy*
Subretinal Fluid
Tomography, Optical Coherence

Substances

Antibodies, Monoclonal
Ipilimumab

Grants and funding